(Q37197672)

18 August 2017

1 reference

title

Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis (English)

1 reference

18 August 2017

0 references

2

Deepak L Bhatt

1 reference

18 August 2017

Anthony A Bavry

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

371

1 reference

18 August 2017

issue

9630

1 reference

18 August 2017

page(s)

2134-2143

1 reference

Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Meta-analysis comparing drug-eluting stents with bare metal stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Drug eluting stents: an updated meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Cause of death with bare metal and sirolimus-eluting stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Bare metal stent restenosis is not a benign clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Drug-eluting stents: dual antiplatelet therapy for every survivor?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Optimal medical therapy with or without PCI for stable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Coronary intervention for persistent occlusion after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Coronary-artery revascularization before elective major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Understanding and minimizing late thrombosis of drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Myocardial infarction as a presentation of clinical in-stent restenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Predictive factors of restenosis after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

In-stent restenosis in small coronary arteries: impact of strut thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Bare-metal stent outcomes in an unselected patient population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Late stent thrombosis in the absence of prior intracoronary brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Development of coronary aneurysm after drug-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Intravascular ultrasound in the drug-eluting stent era.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

1 reference

7 January 2021

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Outcomes and complications associated with off-label and untested use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

President's page: drug-eluting stents in contemporary practice--a call for a real-world, open-entry, device-tracking registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960922-8

7 January 2021

10.1016/S0140-6736(08)60922-8

Identifiers

DOI

1 reference

18 August 2017

1 reference